NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.2802
Dollar change
+0.0177
Percentage change
6.74
%
Index- P/E- EPS (ttm)-1.14 Insider Own9.00% Shs Outstand33.57M Perf Week9.80%
Market Cap9.45M Forward P/E- EPS next Y-0.42 Insider Trans0.00% Shs Float30.68M Perf Month-2.71%
Enterprise Value-10.10M PEG- EPS next Q-0.62 Inst Own17.44% Short Float0.92% Perf Quarter-12.44%
Income-35.86M P/S16.57 EPS this Y13.71% Inst Trans2.16% Short Ratio0.73 Perf Half Y-63.52%
Sales0.57M P/B0.20 EPS next Y60.75% ROA-50.57% Short Interest0.28M Perf YTD-62.64%
Book/sh1.43 P/C0.44 EPS next 5Y37.69% ROE-56.80% 52W High2.23 -87.43% Perf Year-78.93%
Cash/sh0.64 P/FCF- EPS past 3/5Y- -27.40% ROIC-73.26% 52W Low0.23 23.16% Perf 3Y-94.90%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-80.11% 29.07% Gross Margin-272.34% Volatility9.14% 10.23% Perf 5Y-98.50%
Dividend TTM- EV/Sales-17.73 EPS Y/Y TTM11.84% Oper. Margin-7277.19% ATR (14)0.03 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.23 Sales Y/Y TTM-91.22% Profit Margin-6318.09% RSI (14)48.75 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio4.43 EPS Q/Q24.65% SMA200.45% Beta0.59 Target Price5.50
Payout- Debt/Eq0.04 Sales Q/Q-80.11% SMA50-8.45% Rel Volume0.50 Prev Close0.26
Employees132 LT Debt/Eq0.02 EarningsMay 08 AMC SMA200-60.65% Avg Volume385.62K Price0.28
IPOJul 12, 2017 Option/ShortYes / Yes EPS/Sales Surpr.11.11% -74.85% Trades Volume194,228 Change6.74%
Date Action Analyst Rating Change Price Target Change
Aug-12-22Downgrade Sidoti Buy → Neutral $5
Dec-29-21Initiated Sidoti Buy $14
Mar-29-21Downgrade Maxim Group Buy → Hold
May-20-20Upgrade Maxim Group Hold → Buy
May-18-20Reiterated H.C. Wainwright Buy $20 → $35
Mar-09-20Reiterated H.C. Wainwright Buy $4 → $20
Mar-03-20Downgrade Maxim Group Buy → Hold
May-30-25 09:31AM
May-14-25 09:30AM
May-09-25 03:41AM
May-08-25 07:10PM
04:01PM
07:35PM Loading…
May-07-25 07:35PM
05:35PM
Apr-29-25 07:30AM
Apr-02-25 12:00PM
Mar-28-25 08:45AM
03:03AM
Mar-27-25 07:05PM
06:44PM
04:01PM
Mar-19-25 05:20PM
09:30AM Loading…
Mar-13-25 09:30AM
Mar-06-25 03:30PM
Mar-03-25 09:30AM
Feb-24-25 08:18AM
Feb-21-25 04:00PM
Jan-30-25 09:30AM
Jan-07-25 09:30AM
Dec-10-24 09:30AM
Nov-08-24 10:03AM
Nov-07-24 04:01PM
Nov-05-24 09:30AM
Oct-25-24 04:01PM
Oct-21-24 09:30AM
Oct-09-24 05:58PM
Oct-02-24 09:30AM
09:30AM Loading…
Sep-24-24 09:30AM
Sep-05-24 09:30AM
Aug-15-24 09:30AM
Aug-08-24 04:01PM
Jul-29-24 09:30AM
Jul-25-24 09:30AM
Jul-02-24 09:30AM
Jun-18-24 01:30PM
Jun-14-24 09:30AM
May-10-24 01:16PM
May-09-24 08:58PM
04:01PM
Apr-25-24 09:30AM
Apr-24-24 09:30AM
Apr-12-24 09:30AM
Apr-04-24 09:30AM
Mar-21-24 09:30AM
Mar-18-24 09:30AM
Mar-15-24 03:21PM
05:45AM
Mar-14-24 08:55PM
04:01PM
Mar-07-24 09:30AM
Feb-29-24 09:30AM
Feb-01-24 09:30AM
Jan-03-24 09:30AM
Dec-27-23 09:30AM
Nov-29-23 09:30AM
Nov-10-23 03:11PM
01:34PM
Nov-09-23 04:01PM
Nov-02-23 09:30AM
Oct-31-23 09:30AM
Oct-26-23 09:30AM
Oct-23-23 09:30AM
Oct-16-23 09:30AM
Sep-27-23 09:30AM
Sep-22-23 09:30AM
Sep-21-23 09:30AM
Sep-07-23 09:30AM
Aug-29-23 09:30AM
Aug-18-23 09:30AM
Aug-16-23 11:30AM
Aug-13-23 07:51AM
Aug-11-23 05:21AM
Aug-10-23 05:15PM
04:01PM
Jul-27-23 09:30AM
Jul-20-23 09:30AM
Jul-18-23 09:30AM
Jul-13-23 09:30AM
May-18-23 07:21AM
May-11-23 05:25PM
04:01PM
May-09-23 09:30AM
May-05-23 10:35AM
Apr-26-23 09:30AM
Apr-13-23 09:30AM
Mar-23-23 09:26AM
Mar-21-23 09:39AM
Mar-20-23 10:46PM
Mar-17-23 09:30AM
06:38AM
Mar-16-23 05:45PM
04:01PM
Mar-09-23 09:30AM
Mar-02-23 09:30AM
Feb-28-23 12:11PM
Feb-22-23 09:30AM
Feb-02-23 09:30AM
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.